B3gnt2 - UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 Gene

Also Known as BGnT1; BGnT2; B3gnt1; BGnT-1; BGnT-2; B3Galt6; Beta3gnt

Species: Mus musculus

Gene Type: protein coding
Gene ID: 53625

Summary

Predicted to enable N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity. Acts upstream of or within several processes, including axon guidance; cellular response to leukemia inhibitory factor; and sensory perception of smell. Predicted to be located in Golgi apparatus and membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi membrane. Is expressed in several structures, including alimentary system; brain; genitourinary system; immune system; and nose. Orthologous to human B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2). [provided by Alliance of Genome Resources, Apr 2022]

B3gnt2 Products (2)

mRNA Protein Name
NM_001169114.1 NP_001162585.1 N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2
NM_016888.5 NP_058584.3 N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
acts upstream of or within axon guidance IMP
IMP: Inferred from mutant phenotype
15728829 MGI
acts upstream of or within cellular response to leukemia inhibitory factor IEP
IEP: Inferred from expression pattern
20439489 MGI
acts upstream of or within protein glycosylation IMP
IMP: Inferred from mutant phenotype
15728829 MGI
acts upstream of or within sensory perception of smell IMP
IMP: Inferred from mutant phenotype
15728829 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2

  • UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6

  • UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1

  • beta-1,3-Gn-T1

  • beta-1,3-Gn-T2

  • beta-1,3-N-acetylglucosaminyltransferase 1

  • beta-1,3-N-acetylglucosaminyltransferase 2

  • beta3G

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-149777 B3GNT2-IN-1 Inhibitor 99.56% Unkown
HY-RS01310 B3GNT2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19501 B3gnt2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25995 B3gnt2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens B3gnt2 NCBI NCBI:10678